GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (NAS:ALVOW) » Definitions » Ending Cash Position

Alvotech (Alvotech) Ending Cash Position : $64.81 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Ending Cash Position?

Alvotech's Ending Cash Position for the quarter that ended in Mar. 2024 was $64.81 Mil.

Alvotech's quarterly Ending Cash Position declined from Sep. 2023 ($68.32 Mil) to Dec. 2023 ($11.16 Mil) but then increased from Dec. 2023 ($11.16 Mil) to Mar. 2024 ($64.81 Mil).

Alvotech's annual Ending Cash Position increased from Dec. 2021 ($17.56 Mil) to Dec. 2022 ($66.43 Mil) but then declined from Dec. 2022 ($66.43 Mil) to Dec. 2023 ($11.16 Mil).


Alvotech Ending Cash Position Historical Data

The historical data trend for Alvotech's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Ending Cash Position Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
67.40 31.69 17.56 66.43 11.16

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.84 60.47 68.32 11.16 64.81

Alvotech Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Alvotech's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=66.427+-55.27
=11.16

Alvotech's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=11.157+53.654
=64.81


Alvotech Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Alvotech's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Alvotech (Alvotech) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Alvotech (Alvotech) Headlines

From GuruFocus

Alvotech to Participate in Jefferies Healthcare Conference

By GlobeNewswire GlobeNewswire 05-31-2023